R Stock Recent News
R LATEST HEADLINES
Positive momentum from the trial's first stage encouraging Company to accelerate plans for expansion and commercialization White Bear Lake, Minnesota--(Newsfile Corp. - June 10, 2025) - Envoy Medical®, Inc. (NASDAQ: COCH) ("Envoy Medical"), a revolutionary hearing health company focused on fully implanted hearing devices that leverage the ear's natural anatomy, today announced that all 10 of the study participants in the first stage of the Company's pivotal clinical trial for the fully implanted Acclaim® Cochlear Implant have successfully completed their one-month follow-up visits. The investigational sites have reported that the visits are proceeding as expected.
Distribution agreement in Canada under MustGrow's sales and distribution division NexusBioAg. RhizoSorb® releases nutrients in the soil more efficiently to reduce phosphorus use by up to 50% while maximizing crop yield.
R grapples with rising operating costs and a weak current ratio, signaling ongoing financial strain in the company's operations.
Ryder System's strategic shift to contract and supply chain management has reduced earnings volatility and protected cash flow from macroeconomic swings. Disciplined fleet management and long-term contracts help Ryder weather trucking industry cyclicality, despite near-term economic uncertainty and softer rental demand. Strong Q1 results, robust free cash flow, and ongoing capital returns (dividends, buybacks) highlight Ryder's financial flexibility and resilience.
Ryder System remains a solid 'buy' due to its consistently low valuation versus peers and solid long-term performance, despite recent short-term stock weakness. Revenue and profitability continue to grow, driven by strategic acquisitions and the expanding ChoiceLease program, even as some segments face softness. Management projects modest revenue growth, but a significant 10% increase in net profits for 2025, supported by pricing and cost initiatives.
MIAMI--(BUSINESS WIRE)--Ryder System, Inc. (NYSE: R) Chairman & CEO Robert Sanchez to address Wells Fargo Industrials & Materials Conference. Who: Ryder System, Inc. Chairman & CEO Robert Sanchez What: Wells Fargo Industrials & Materials Conference When: Wednesday, June 11, 2025 Time: 8:45 a.m. CDT Webcast: To access the live webcast, visit http://investors.ryder.com. About Ryder System, Inc. Ryder System, Inc. (NYSE: R) is a fully integrated port-to-door logistics and transport.
Vancouver, British Columbia--(Newsfile Corp. - June 2, 2025) - Delivra Health Brands Inc. (TSXV: DHB) (OTCQB: DHBUF) ("Delivra Health" or the "Company"), a consumer packaged goods company uniquely positioned in the health and wellness sector, is pleased to announce that it has further expanded its presence in the United States by partnering with the Quality Value Convenience (the "QVC"), a leading USA televised and online shopping network that specializes in live product demonstrations and direct-to-consumer sales. "Once again, our team has been focused on expanding distribution and access points for all types of consumers," said Gord Davey, President and Chief Executive Officer of Delivra Health.
LOWELL, MA / ACCESS Newswire / June 2, 2025 / CSP Inc. (NASDAQ:CSPI), an award-winning provider of security and packet capture products, managed IT and professional services and technology solutions, today announced that it has been added as a member of the broad-market Russell 3000® Index, effective after the US market opens on June 30, as part of the 2025 Russell indexes reconstitution. "This is a significant milestone and reflects the excitement and growth potential of our emerging AZT PROTECT business," commented Victor Dellovo, Chief Executive Officer.
Brisbane, Queensland, Australia--(Newsfile Corp. - May 27, 2025) - Graphene Manufacturing Group Ltd. (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the "Company") is pleased to announce the following internal GMG run engine test results when G® Lubricant was added to a Caterpillar 22 kVA diesel engine run at an 80% Load.
Ryder (R) reported earnings 30 days ago. What's next for the stock?